Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperuricemia and gout: an update.

A K Khachadurian

    American Family Physician
    |December 1, 1981
    PubMed
    Summary

    Gout is a disorder caused by uric acid imbalance. Treatment strategies vary depending on the specific condition, such as tophi or uric acid stones, with medication choices guided by the underlying mechanism.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Red wine inhibits the cell-mediated oxidation of LDL and HDL.

    Journal of the American College of Nutrition·1999
    Same author

    Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity.

    Metabolism: clinical and experimental·1999
    Same author

    Administration of antioxidant vitamins does not alter plasma fibrinolytic activity in subjects with central obesity.

    Thrombosis and haemostasis·1997
    Same author

    Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux.

    Atherosclerosis·1996
    Same author

    Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages.

    Biochimica et biophysica acta·1996
    Same author

    Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I.

    Atherosclerosis·1994

    Area of Science:

    • Rheumatology
    • Nephrology
    • Metabolic Disorders

    Background:

    • Gout is a complex disorder with primary and secondary forms.
    • Uric acid metabolism abnormalities (overproduction or underexcretion) are central to gout pathogenesis.
    • The management of asymptomatic hyperuricemia remains a topic of debate.

    Purpose of the Study:

    • To outline the mechanisms and treatment principles for various manifestations of gout.
    • To differentiate treatment approaches based on clinical presentation and underlying pathophysiology.
    • To provide guidance on pharmacotherapy for gout-related complications.

    Main Methods:

    • Review of existing literature on gout pathophysiology and treatment.
    • Analysis of mechanisms leading to hyperuricemia.
    • Evaluation of therapeutic options for gout, tophi, uric acid stones, and renal insufficiency.

    Main Results:

    • Gout can stem from primary or secondary causes, often linked to uric acid handling.
    • Tophi management necessitates a combination of uricosurics and allopurinol.
    • Xanthine oxidase inhibitors are recommended for uric acid stones and renal impairment.

    Conclusions:

    • Understanding the specific mechanism of uric acid imbalance is crucial for effective gout management.
    • Tailored therapeutic strategies are required for different gout presentations.
    • Pharmacological interventions should be selected based on the presence of tophi, stones, or renal compromise.

    Related Experiment Videos